603707 健友股份
午间休市 07-23 11:29:33
资讯
新帖
简况
健友股份：FDA对中国厂区现场核查标准持续收紧
证券之星 · 07-22 16:42
健友股份：FDA对中国厂区现场核查标准持续收紧
股市必读：健友股份（603707）7月16日董秘有最新回复
证券之星 · 07-17
股市必读：健友股份（603707）7月16日董秘有最新回复
健友股份：公司及管理层严格遵守证券监管法规
证券之星 · 07-16
健友股份：公司及管理层严格遵守证券监管法规
健友股份：研发注册生产及全球商业化全链条布局
证券之星 · 07-16
健友股份：研发注册生产及全球商业化全链条布局
健友股份：不存在隐瞒重大利空情形
证券之星 · 07-16
健友股份：不存在隐瞒重大利空情形
股市必读：健友股份（603707）7月10日董秘有最新回复
证券之星 · 07-13
股市必读：健友股份（603707）7月10日董秘有最新回复
每周股票复盘：健友股份（603707）获丙泊酚注射液注册批件
证券之星 · 07-12
每周股票复盘：健友股份（603707）获丙泊酚注射液注册批件
健友股份：小分子注射剂每年获批计十余款
证券之星 · 07-10
健友股份：小分子注射剂每年获批计十余款
健友股份：与通化东宝战略合作核心聚焦于美国市场
证券之星 · 07-10
健友股份：与通化东宝战略合作核心聚焦于美国市场
健友股份：当前股价下跌主要受全市场医药板块情绪、短期利润阶段性承压影响
证券之星 · 07-10
健友股份：当前股价下跌主要受全市场医药板块情绪、短期利润阶段性承压影响
健友股份（603707）披露子公司获美国FDA醋酸去氨加压素注射液生产场地转移注册批件，7月6日股价下跌0.39%
证券之星 · 07-06
健友股份（603707）披露子公司获美国FDA醋酸去氨加压素注射液生产场地转移注册批件，7月6日股价下跌0.39%
健友股份(603707.SH)获得丙泊酚乳状注射液药品注册批件
智通财经 · 07-06
健友股份(603707.SH)获得丙泊酚乳状注射液药品注册批件
每周股票复盘：健友股份（603707）子公司获FDA批件完善海外供应链
证券之星 · 07-05
每周股票复盘：健友股份（603707）子公司获FDA批件完善海外供应链
健友股份(603707.SH)子公司获得美国FDA醋酸去氨加压素注射液药品生产场地转移注册批件
智通财经 · 07-03
健友股份(603707.SH)子公司获得美国FDA醋酸去氨加压素注射液药品生产场地转移注册批件
6月29日健友股份涨6.14%，摩根强化回报债券A基金重仓该股
证券之星 · 06-29
6月29日健友股份涨6.14%，摩根强化回报债券A基金重仓该股
董秘说|健友股份董秘黄锡伟：锚定全球化布局，三步走夯实制药全产业链成长
新浪财经 · 06-22
董秘说|健友股份董秘黄锡伟：锚定全球化布局，三步走夯实制药全产业链成长
每周股票复盘：健友股份（603707）每股派现0.10元含税
证券之星 · 06-07
每周股票复盘：健友股份（603707）每股派现0.10元含税
健友股份（603707）披露差异化分红专项法律意见，6月2日股价下跌1.57%
证券之星 · 06-02
健友股份（603707）披露差异化分红专项法律意见，6月2日股价下跌1.57%
每周股票复盘：健友股份（603707）完成董事会换届选举
证券之星 · 05-24
每周股票复盘：健友股份（603707）完成董事会换届选举
健友股份（603707）披露2025年年度股东会决议公告，5月21日股价下跌1.07%
证券之星 · 05-21
健友股份（603707）披露2025年年度股东会决议公告，5月21日股价下跌1.07%
加载更多
公司概况
公司名称：
南京健友生化制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-19
主营业务：
南京健友生化制药股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是标准肝素原料药、制剂、CDMO。截至报告期末，公司及子公司共拥有超过100项境外药品注册批件、超过30项中国药品注册批件。
发行价格：
7.21
{"stockData":{"symbol":"603707","market":"SH","secType":"STK","nameCN":"健友股份","latestPrice":7.78,"timestamp":1784777373000,"preClose":7.87,"halted":0,"volume":6014831,"delay":0,"changeRate":-0.0114,"floatShares":1616000000,"shares":1616000000,"eps":0.3626,"marketStatus":"午间休市","change":-0.09,"latestTime":"07-23 11:29:33","open":7.83,"high":7.88,"low":7.7,"amount":46797000,"amplitude":0.0229,"askPrice":7.79,"askSize":270,"bidPrice":7.78,"bidSize":60,"shortable":0,"etf":0,"ttmEps":0.3626,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784782800000},"marketStatusCode":3,"adr":0,"adjPreClose":7.87,"symbolType":"stock","openAndCloseTimeList":[[1784770200000,1784777400000],[1784782800000,1784790000000]],"highLimit":8.66,"lowLimit":7.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1615651020,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":21.45615,"roe":"1.28%","epsLYR":0.36,"committee":-0.267259,"marketValue":12570000000,"turnoverRate":0.0037,"status":1,"floatMarketCap":12570000000},"requestUrl":"/m/hq/s/603707","defaultTab":"news","newsList":[{"id":"2653536737","title":"健友股份：FDA对中国厂区现场核查标准持续收紧","url":"https://stock-news.laohu8.com/highlight/detail?id=2653536737","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653536737?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:42","pubTimestamp":1784709743,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份(603707)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问：看新闻最近有好几家药企都收到了FDA监管文件，健友目前有没有类似风险？健友股份回复：尊敬的投资者您好，公司高度关注同业出海企业的监管动态。整体看，FDA对中国厂区的现场核查标准持续收紧，生产质量体系的稳定性已成为出海药企能否顺利获批的核心变量。公司深耕肝素及无菌注射剂领域二十余年，目前拥有12条通过美国FDA审核的注射剂生产线，各产线运行稳定，公司将持续保持对质量体系的高标准投入。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200034111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","BK0239","BK0046","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426010","title":"股市必读：健友股份（603707）7月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426010","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652426010?lang=zh_cn&edition=full","pubTime":"2026-07-17 01:40","pubTimestamp":1784223620,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，健友股份报收于8.28元，上涨3.63%，换手率1.59%，成交量25.64万手，成交额2.09亿元。董秘最新回复投资者： 想问下公司截至提问之日的股东人数。董秘： 投资者您好，相关疑问回复如下：1、公司及管理层严格遵守证券监管法规，不存在配合资金控盘、打压股价等违法违规行为，二级市场股价受宏观、行业、资金情绪等多重因素影响，公司无法左右股价走势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700000897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196443","title":"健友股份：公司及管理层严格遵守证券监管法规","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651196443?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:06","pubTimestamp":1784196382,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月16日在投资者关系平台上答复投资者关心的问题。健友股份回复：投资者您好，相关疑问回复如下：1、公司及管理层严格遵守证券监管法规，不存在配合资金控盘、打压股价等违法违规行为，二级市场股价受宏观、行业、资金情绪等多重因素影响，公司无法左右股价走势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600031900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651443160","title":"健友股份：研发注册生产及全球商业化全链条布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651443160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651443160?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:06","pubTimestamp":1784196381,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月16日在投资者关系平台上答复投资者关心的问题。而健友的定位是研发、注册、生产以及全球商业化全链条布局，也是国内少数自建美国完整营销团队、新加坡区域运营中心、高端无菌产能的企业。公司的业务布局不只是 “产品出海”，而是输出整套合规制造、国际申报、本地化销售能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600031898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0046","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651448247","title":"健友股份：不存在隐瞒重大利空情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2651448247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651448247?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:51","pubTimestamp":1784195477,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月16日在投资者关系平台上答复投资者关心的问题。当前股价下跌主要受全市场医药板块情绪、短期利润阶段性承压影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600029405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603707","BK0239","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651165704","title":"股市必读：健友股份（603707）7月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651165704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651165704?lang=zh_cn&edition=full","pubTime":"2026-07-13 01:41","pubTimestamp":1783878068,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，健友股份报收于7.49元，上涨3.45%，换手率0.94%，成交量15.22万手，成交额1.13亿元。董秘最新回复投资者： 现在公司股价持续下行，是否存在市场对公司价值逻辑的认知偏差？目前公司与通化东宝的战略合作核心聚焦于美国市场。公司将持续跟踪全球各法规市场的政策与行业机遇，稳步推进生物药的全球化布局，后续若有重大合作进展或注册获批事项，公司将及时披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300000854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","BK0046","BK0186","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650502154","title":"每周股票复盘：健友股份（603707）获丙泊酚注射液注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2650502154","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650502154?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:16","pubTimestamp":1783793770,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，健友股份报收于7.49元，较上周的7.64元下跌1.96%。本周，健友股份7月6日盘中最高价报7.74元。本周关注点公司公告汇总：健友股份获丙泊酚乳状注射液药品注册批件，视同通过一致性评价。丙泊酚乳状注射液适用于全身麻醉诱导与维持、重症监护成年患者镇静及临床操作清醒镇静。此次获批标志着公司具备该产品境内上市销售资格，有助于完善产品管线布局，提升市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","BK0046","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913189","title":"健友股份：小分子注射剂每年获批计十余款","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913189","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650913189?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:45","pubTimestamp":1783676721,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月10日在投资者关系平台上答复投资者关心的问题。介绍一下未来2-3年申报获批规划，以及现有产能能否匹配后续需求？健友股份回复：尊敬的投资者您好，公司小分子注射剂每年获批计十余款，聚焦麻醉、抗肿瘤等高壁垒赛道，现有12条FDA无菌产线可支撑近三年放量。生物药方面，利拉鲁肽FDA获批后持续海外销售；阿达木单抗已在美上市；在研单抗XTMAB正推进三期临床。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000032240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650186077","title":"健友股份：与通化东宝战略合作核心聚焦于美国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2650186077","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650186077?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:33","pubTimestamp":1783676003,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月10日在投资者关系平台上答复投资者关心的问题。年报显示，门冬胰岛素正在向欧洲和美国获批中，跟通化东宝的合作未来也包含欧洲市场吗？目前公司与通化东宝的战略合作核心聚焦于美国市场。公司已获得包括门冬胰岛素等相关产品在美国的独家商业化权益，合作协议范围尚未包含欧洲市场。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600867","BK0186","BK0046","603707","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650078186","title":"健友股份：当前股价下跌主要受全市场医药板块情绪、短期利润阶段性承压影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2650078186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650078186?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:33","pubTimestamp":1783675998,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份07月10日在投资者关系平台上答复投资者关心的问题。目前公司海外制剂与生物药业务增长动能充足，核心研发管线稳步推进，基本面转型逻辑持续兑现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK0186","BK0046","BK1161","159938","603707","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649628854","title":"健友股份（603707）披露子公司获美国FDA醋酸去氨加压素注射液生产场地转移注册批件，7月6日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649628854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649628854?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:43","pubTimestamp":1783331038,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，健友股份报收于7.61元，较前一交易日下跌0.39%，最新总市值为122.95亿元。近日，南京健友生化制药股份有限公司子公司Meitheal Pharmaceuticals, Inc.收到美国FDA通知，其申报的醋酸去氨加压素注射液生产场地转移至健进制药有限公司的申请已获批准。此次获批表明公司无菌注射剂生产线及质量体系符合美国cGMP标准，有助于丰富北美医疗机构注射剂产品线，完善海外供应链体系，中长期有望对公司经营业绩产生积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600025190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0046","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649264219","title":"健友股份(603707.SH)获得丙泊酚乳状注射液药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2649264219","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649264219?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:37","pubTimestamp":1783327022,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健友股份(603707.SH)发布公告，公司于近日收到国家药品监督管理局(简称“NMPA”)签发的丙泊酚乳状注射液20ml：200mg的药品注册证书(药品批准文号为国药准字H20264830)。适应症：本品为短效静脉麻醉药，临床用于全身麻醉诱导与维持;重症监护成年机械通气患者镇静;外科手术、临床诊断操作的清醒镇静。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"健友股份(603707.SH)获得丙泊酚乳状注射液药品注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0186","BK0046","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694296","title":"每周股票复盘：健友股份（603707）子公司获FDA批件完善海外供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694296","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649694296?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:48","pubTimestamp":1783190891,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，健友股份报收于7.64元，较上周的6.84元上涨11.7%。本周，健友股份7月3日盘中最高价报7.72元。此次获批表明公司无菌注射剂生产线及质量体系符合美国cGMP标准，有助于丰富公司北美医疗机构注射剂产品线，进一步完善海外供应链体系，中长期有望对公司经营业绩产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648076654","title":"健友股份(603707.SH)子公司获得美国FDA醋酸去氨加压素注射液药品生产场地转移注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2648076654","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648076654?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:34","pubTimestamp":1783067659,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 健友股份(603707.SH)发布公告，公司子公司Meitheal Pharmaceuticals, Inc.(以下简称“Meitheal”)于近日收到美国食品药品监督管理局(以下简称“美国FDA”)签发的醋酸去氨加压素注射液，4mcg/mL 和40mcg/10mL(ANDA号：074888)生产场地转移批准信，批准在公司子公司健进制药有限公司场地生产。本次获批印证公司无菌注射剂生产线及质量体系满足美国cGMP标准，丰富公司北美医疗机构注射剂管线，完善海外自有供应链体系，中长期有望为公司经营业绩带来积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","603707","BK4588","BK0239","LABU","BK4585","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647241773","title":"6月29日健友股份涨6.14%，摩根强化回报债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647241773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647241773?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:33","pubTimestamp":1782722021,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日健友股份涨6.14%创60日新低，收盘报7.26元，换手率1.46%，成交量23.61万手，成交额1.69亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为摩根基金(中国)的摩根强化回报债券A。摩根强化回报债券A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603707","BK0186","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645042867","title":"董秘说|健友股份董秘黄锡伟：锚定全球化布局，三步走夯实制药全产业链成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2645042867","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645042867?lang=zh_cn&edition=full","pubTime":"2026-06-22 15:41","pubTimestamp":1782114060,"startTime":"0","endTime":"0","summary":" 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 在资本市场高质量发展的新阶段，上市公司价值传递的枢纽——董事会秘书，始终是连接企业与万千投资者的坚实桥梁，是资本品牌的核心锻造者与市场信任的关键构建者。由新浪财经主办的第十二届金麒麟·金牌董秘评选火热进行中，评选期间推出《董秘说》专访活动，助力投资者深入了解上市公司资本价值和发展战略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-06-22/doc-iniehmvv9317391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK0046","BK1191","BK0186","603707","BK0239","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127279","title":"每周股票复盘：健友股份（603707）每股派现0.10元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127279","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127279?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:00","pubTimestamp":1780772438,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，健友股份报收于8.04元，较上周的8.08元下跌0.5%。本周，健友股份6月1日盘中最高价报8.33元。本周关注点公司公告汇总：健友股份2025年年度权益分派实施公告显示，每股现金红利0.10元（含税）。个人股东根据持股期限适用20%、10%或免税政策；QFII及沪股通股东按10%税率代扣所得税。本次利润分配以实施权益分派股权登记日登记的总股本为基数，每10股派发现金红利1.00元（含税），实际参与分配的股份数量为1,613,722,425股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0186","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640441949","title":"健友股份（603707）披露差异化分红专项法律意见，6月2日股价下跌1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640441949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640441949?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:26","pubTimestamp":1780410387,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，健友股份报收于8.15元，较前一交易日下跌1.57%，最新总市值为131.68亿元。近日，江苏世纪同仁律师事务所出具《关于南京健友生化制药股份有限公司差异化分红的专项法律意见》。公告显示，南京健友生化制药股份有限公司因实施股份回购，导致公司回购专用账户持有的1,928,595股股份不参与2025年度利润分配，构成差异化分红。经测算，差异化分红对除权除息参考价格的影响低于1%，符合相关法律法规及公司章程规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603707","BK0186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637926375","title":"每周股票复盘：健友股份（603707）完成董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2637926375","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637926375?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:40","pubTimestamp":1779565221,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，健友股份报收于8.21元，较上周的8.7元下跌5.63%。本周关注点来自公司公告汇总：健友股份完成第六届董事会换届选举，唐咏群当选董事长兼总经理。健友股份于2026年5月20日完成董事会换届选举，唐咏群、谢菊华、王涛、蔡建、金毅当选非职工代表董事，黄锡伟为职工代表董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384294","title":"健友股份（603707）披露2025年年度股东会决议公告，5月21日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637384294?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:10","pubTimestamp":1779358226,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，健友股份报收于8.3元，较前一交易日下跌1.07%，最新总市值为134.1亿元。该股当日开盘8.35元，最高8.51元，最低8.26元，成交额达7381.13万元，换手率为0.54%。公司于2026年5月21日披露《2025年年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","BK0239","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784780880486,"stockEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":0.1116},{"period":"3month","weight":-0.1494},{"period":"6month","weight":-0.18},{"period":"1year","weight":-0.2971},{"period":"ytd","weight":-0.1173}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0711},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0651},{"period":"1year","weight":0.0796},{"period":"ytd","weight":-0.0257}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京健友生化制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35693人(较上一季度减少6.31%)","perCapita":"45265股","listingDate":"2017-07-19","address":"江苏省南京市浦口区高新开发区MA010-1号地","registeredCapital":"161565万元","survey":" 南京健友生化制药股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是标准肝素原料药、制剂、CDMO。截至报告期末，公司及子公司共拥有超过100项境外药品注册批件、超过30项中国药品注册批件。","listedPrice":7.21},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健友股份,603707,健友股份股票,健友股份股票老虎,健友股份股票老虎国际,健友股份行情,健友股份股票行情,健友股份股价,健友股份股市,健友股份股票价格,健友股份股票交易,健友股份股票购买,健友股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}